uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Profit After Tax (2016 - 2026)

uniQure (QURE) posted Profit After Tax of -$81.1 million for Q2 2026, down 46.85% on a QoQ basis from -$55.2 million in Q1 2026, and down 89.31% year-over-year from -$758.6 million in Q2 2025.

Analysis

uniQure (QURE) Profit After Tax (2016 - 2026) Analysis & Trends

uniQure has reported Profit After Tax for 11 years, with the latest figure at -$81.1 million in Q2 2026.

  • On a quarterly basis, Profit After Tax fell 89.31% year-over-year to -$81.1 million in Q2 2026; TTM through Jun 2026 was -$253.3 million, a 25.22% decrease from a year earlier, with the FY2025 full-year figure at -$204.4 million, up 14.68% from the prior year.
  • Profit After Tax was -$81.1 million for Q2 2026 at uniQure, down from -$55.2 million in the prior quarter.
  • The five-year high for Profit After Tax was $41.5 million in Q4 2022, with the low at -$95.7 million in Q3 2023.
  • Average Profit After Tax over 5 years is -$58.1 million, with a median of -$67.7 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 1601.48% in 2022, then plunged 275.69% in 2023.
  • Over 5 years, Profit After Tax stood at $41.5 million in 2022, then slumped by 275.69% to -$72.9 million in 2023, then advanced by 3.87% to -$70.1 million in 2024, then surged by 47.85% to -$36.6 million in 2025, then tumbled by 121.7% to -$81.1 million in 2026.
  • The last three Profit After Tax figures came in at -$81.1 million (Q2 2026), -$55.2 million (Q1 2026), and -$36.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 5.53 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 3.62 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.51 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.50 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -248.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.10 Bn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn -81.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -81.06 Mn
Mar 31, 2026 -55.20 Mn
Dec 31, 2025 -36.56 Mn
Sep 30, 2025 -80.53 Mn
Jun 30, 2025 -42.82 Mn
Mar 31, 2025 -44.64 Mn
Dec 31, 2024 -70.12 Mn
Sep 30, 2024 -44.76 Mn
Jun 30, 2024 -56.58 Mn
Mar 31, 2024 -68.11 Mn
Dec 31, 2023 -72.94 Mn
Sep 30, 2023 -95.69 Mn
Jun 30, 2023 -68.42 Mn
Mar 31, 2023 -71.43 Mn
Dec 31, 2022 41.52 Mn
Sep 30, 2022 -73.23 Mn
Jun 30, 2022 -67.39 Mn
Mar 31, 2022 -57.13 Mn
Dec 31, 2021 -2.77 Mn
Sep 30, 2021 -49.82 Mn
API Access

uniQure Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=QURE&period=max&api_key=YOUR_API_KEY